Avandia (Rosiglitazone) – Study Finds Increased Rate of Heart Attacks and Death From Heart Related Vascular (Cardiovascular) Disease, Such as Congestive Heart Failure or CHF or Stroke – FDA Issues Safety Alert
Avandia (Rosiglitazone) is a widely prescribed medication to treat Type-2 Diabetes Mellitus, a condition which also known as Adult-Onset Diabetes. Manufactured by GlaxoSmithKline, Avandia (Rosiglitazone) was approved for the treatment of Type-2 Diabetes in the U.S. in 1999. Avandia is also contained in combination with other drugs in medications called Avandaryl and Avandamet. To date, more than six million people worldwide have taken the drug, and Avandia generates approximately $3.2 billion in annual sales for its manufacturer. However, on May 21, 2007, the United States Food and Drug Administration (“FDA”) issued a Safety Alert regarding Avandia. There has not yet been a recall or a black box warning required by the FDA for Avandia, but in the event this product is recalled, this site will be updated.
The FDA Safety Alert warns that patients who are taking Avandia (Rosiglitazone) – especially those who are known to have underlying heart disease or who are at high risk of heart attack (myocardial infarction) – should speak to their physicians about their continued use of Avandia.
The FDA’s Safety Alert follows a study released on the same day which appears in the June 14, 2007 issue of the New England Journal of Medicine. This type of study, known as a “meta-analysis,” evaluated forty-two (42) separate studies, comparing patients using Avandia (Rosiglitazone) to patients who were not using Avandia. This study concludes that patients taking Avandia (Rosiglitazone) face a 43% increased risk of heart attack, and a 64% increased risk of dying from heart-related (cardiovascular) disease, such as congestive heart failure or CHF. Cardiovascular disease refers to the class of diseases that affect the heart and/or blood vessels, which includes but is not limited to heart attacks (myocardial infarction), congestive heart failure, and strokes. As indicated above, there has not yet been a recall.
If you or a loved one has experienced a heart attack or stroke or has died of heart related (cardiovascular) disease or a stroke after using the diabetes medication Avandia, you may have a lawsuit that should be pursued. Our drug litigation practice is national in scope, and our Avandia lawyers are prepared to file lawsuits and litigate Avandia cases around the country. Our attorneys can help to ascertain if you have an Avandia claim for which a lawsuit can be pursued and whether the case and lawsuit can be brought to a successful settlement, verdict, award, or other recovery. The experienced lawyer will also be able to advise you on any deadlines for bringing your legal claim for damages.
We have a toll-free (no cost) telephone number to reach an attorney to answer your questions with regard to your specific case. That number is 1-888-LAW-4335. If you would prefer, please feel free to fill out the “Contact Us” form on our website. Be sure to include your name, address, telephone number, e-mail address, and the exact nature of your question so that our lawyer can provide you with the specific information you seek.